Kerala Ayurveda Ltd (KERALAYUR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Kerala Ayurveda Ltd on NSE and BSE, with an AI summary of each filing.
Announcement under Regulation 30(LODR) - Allotment
Others (Uncategorized) · 21 Oct 2026, 6:34 pm
Kerala Ayurveda Approves ₹12.47 Cr Preferential Equity Allotment via Debt Conversion Kerala Ayurveda approved the preferential allotment of 6,55,000 equity shares (face value ₹10) at ₹190.37 per share, aggregating to ₹12.47 Cr, on 21st Oct'26 to promoter entity Katra Holding Private Limited. The allotment is executed by partially adjusting an existing unsecured loan of ₹12.47 Cr. Following this conversion, Katra Holding’s stake increases from 4.85% (6,30,000 shares) to 9.41% (12,85,000 shares). Concurrently, the company's total paid-up equity share capital expanded from ₹12.99 Cr (1.29 Cr shares) to ₹13.65 Cr (1.36 Cr shares).
Shareholders meeting - Scrutinizer''s Report
Annual General Meeting · 30 Sept 2026, 2:19 am
Kerala Ayurveda Shareholders Approve Preferential Equity Issue and FY26 Financials Kerala Ayurveda Limited announced that shareholders approved all resolutions at its 34th AGM held on 28th Sep'26 with requisite majorities. Key approvals include the adoption of FY26 audited standalone and consolidated financial statements (98.83% in favour), the re-appointment of director Ramesh Vangal, and the ratification of cost auditor remuneration. Additionally, shareholders passed a special resolution with 98.83% approval to issue 6,55,000 equity shares on a preferential basis to promoter entity Katra Holding Private Limited via partial adjustment against existing unsecured loans.
AGM Proceedings.
Annual General Meeting · 28 Sept 2026, 11:43 pm
AGM Proceedings
Annual General Meeting · 28 Sept 2026, 11:39 pm
Corrigendum to the AGM Notice
Annual General Meeting · 23 Sept 2026, 12:10 am
Intimation for Corrigendum to the notice of 34th AGM of Kerala Ayurveda Limited with respect to Preferential Issue.
Others (Uncategorized) · 23 Sept 2026, 12:05 am
Notice of the 34th Annual General Meeting of the Company
Annual General Meeting · 06 Sept 2026, 4:32 am
Annual Report of Kerala Ayurveda Limited for FY 2025-26.
Others (Uncategorized) · 06 Sept 2026, 4:29 am
The Board of Directors of Kerala Ayurveda Limited approved Preferential Issue of Equity shares subject to the approval of the shareholders.
Others (Uncategorized) · 04 Sept 2026, 6:06 pm
Kerala Ayurveda Approves Preferential Issue to Promoter Group for Loan Conversion On 4th Sep'26, Kerala Ayurveda's Board approved a preferential issue of 7,20,000 equity shares at Rs. 190.37 per share to Katra Holding Private Limited, a promoter group entity. This issuance, aggregating to Rs. 13.71 crore, will partially convert an outstanding unsecured loan of Rs. 26.41 crore into equity. Consequently, Katra Holding's stake will increase from 4.85% to 9.84%, expanding their holding from 6,30,000 to 13,50,000 shares. The allotment remains subject to shareholder approval at the upcoming AGM scheduled for 28th Sep'26.
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve Inter alia to Consider and ....
Intimation · 01 Sept 2026, 11:50 pm
Kerala Ayurveda Board to Consider Preferential Share Issue Kerala Ayurveda's Board of Directors will meet on 04 Sep'26 to consider and evaluate a proposal for a preferential issue of equity shares in one or more tranches. The Board will also convene the company's 34th Annual General Meeting (AGM), scheduled for 28 Sep'26. The trading window for designated persons is closed and will reopen 48 hours after the Board meeting's outcome is announced. The potential equity issuance could lead to dilution for existing shareholders.
Announcement under Regulation 30 (LODR)- Scheme of Arrangement
Others (Uncategorized) · 13 Aug 2026, 12:49 am
Kerala Ayurveda Approves Subsidiary Merger, ESOPs, and Reports Q1FY27 Results Kerala Ayurveda's board, on 12 Aug'26, approved Q1FY27 results and key strategic actions. Consolidated revenue was ₹3,345.36 lakhs with a net loss of ₹665.04 lakhs. The board sanctioned the amalgamation of its wholly-owned subsidiary, Ayurvedagram Heritage Wellness Centre, with the company to streamline operations. Additionally, it approved the grant of 64,875 ESOPs under its 2023 plan at an exercise price of ₹10 per option. The re-appointment of Non-Executive Director Mr. Ramesh Vangal was also proposed, subject to shareholder approval.
Announcement under Regulation 30(LODR)- Press Release
Press Release · 13 Aug 2026, 12:41 am
Kerala Ayurveda Q1 FY27 Results: Growth Continues, Path to Breakeven Reaffirmed Kerala Ayurveda's Q1 FY27 revenue grew 16.0% YoY to ₹33.2 Cr, driven by strong performance in the Global E-Product (+32.3%) and Standalone (+28.3%) businesses. The company's Operating EBITDA (Adj.) loss halved QoQ to -₹3.82 Cr, showing improved operating leverage from better margins and cost discipline. Management reaffirmed its path to achieving monthly Operating EBITDA breakeven by Sep'26. The firm remains on track for its Vision 2030 goal of ₹1,000 Cr revenue and plans to convert promoter loans to equity in H2 FY27.
Announcement under Regulation 30 (LODR) - Allotment of ESOP
Others (Uncategorized) · 13 Aug 2026, 12:36 am
Kerala Ayurveda: Q1FY27 Loss, Subsidiary Merger, and ESOP Grant Kerala Ayurveda's Board approved unaudited Q1FY27 results on 12 Aug'26. Consolidated revenue was ₹3,345.36 lakh, with a net loss of ₹665.04 lakh versus a profit of ₹231.07 lakh YoY. Standalone revenue was ₹2,380.66 lakh with a net loss of ₹766.89 lakh. The Board approved the amalgamation of its wholly-owned subsidiary, Ayurvedagram Heritage Wellness Centre, with the company. Additionally, 64,875 ESOPs were granted under the RSU Plan 2023. A proposal for the re-appointment of Non-Executive Director Mr. Ramesh Vangal was also approved.
Results - Financial Results for the Quarter ended 30th June 2026
Financial Result · 12 Aug 2026, 9:20 pm
Kerala Ayurveda Q1FY27 Results, Merger Plan, and ESOP Grant Announced Kerala Ayurveda approved Q1FY27 results, the amalgamation of its wholly-owned subsidiary Ayurvedagram Heritage Wellness Centre, and a grant of 64,875 ESOPs on 12 Aug'26. For the quarter ending 30 Jun'26, consolidated net loss stood at ₹665.04 lakhs on revenue of ₹3,319.29 lakhs, compared to a profit of ₹231.07 lakhs YoY. The merger with Ayurvedagram (FY26 turnover: ₹1,546.69 lakhs) aims for operational synergies. The Board also proposed the re-appointment of Non-Executive Director Mr. Ramesh Vangal.
Outcome of Board 12th August 2026
Outcome · 12 Aug 2026, 9:10 pm
Kerala Ayurveda Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 3,319 (+16.0% YoY | -4.4% QoQ) ■ EBITDA: -383 (+8.5% YoY | +46.1% QoQ) ■ EBITDA Margin (%): -11.5 (+309 bps YoY | +890 bps QoQ) ■ PAT: -798 (Profit to Loss YoY | -2.8% QoQ) ■ EPS (INR): -6.24 (Profit to Loss YoY | -7.0% QoQ)
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the unaudited financial results ....
Intimation · 12 Aug 2026, 5:30 am
Kerala Ayurveda Board Meeting Set for Aug 12, 2026, to Approve Q1 Results Kerala Ayurveda Limited has scheduled a Board of Directors meeting for Aug 12, '26. The agenda includes the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended Jun 30, '26. The trading window for designated persons has been closed since Jun 30, '26, and will reopen 48 hours after the financial results are publicly announced.
Revised Corporate announcement Pursuant to the query raised from BSE
Change in Management · 10 Jun 2026, 10:47 pm
Kerala Ayurveda Appoints Binu Thomas as Company Secretary and Compliance Officer Kerala Ayurveda Limited has appointed Mr. Binu Thomas as its new Company Secretary and Compliance Officer, effective 09 Jun'26. The appointment was approved by the Board of Directors in their meeting on the same day. Mr. Thomas is a Fellow Member of ICSI and holds an MBA. He brings over 10 years of post-qualification experience in secretarial and compliance functions for listed entities. Prior to this role, he served as Company Secretary and Compliance Officer at Harrisons Malayalam Limited.
Resignation of Independent Director
Change in Management · 09 Jun 2026, 4:42 pm
Kerala Ayurveda: Independent Director Resigns Mr. Samir Dhawan Agarwal (DIN: 01178691) has resigned from his position as an Independent Director at Kerala Ayurveda Limited, effective from the close of business on 09 Jun'26. The company filing cited other professional commitments requiring his increased time and attention as the reason. The resignation letter confirmed there are no other material reasons for his departure. According to the disclosure, Mr. Agarwal holds no other directorships in any listed entities.
Intimation under regulation 30(5)
Others (Uncategorized) · 09 Jun 2026, 4:24 pm
Kerala Ayurveda Authorizes Key Personnel for Materiality Determination On 9th Jun'26, Kerala Ayurveda Limited (Scrip Code: 530163) authorized four Key Managerial Personnel (KMPs) to determine the materiality of information for stock exchange disclosures under SEBI regulations. The authorized individuals are WTD Kunjupanicker Anil Kumar, CEO Vivek Sunder, CFO George K T, and CS Binu Thomas. This designation empowers them to manage the flow of material information to investors and exchanges, ensuring regulatory compliance.
Appointment of Company secretary and Compliance officer
Change in Management · 09 Jun 2026, 4:19 pm
Kerala Ayurveda Appoints Binu Thomas as Company Secretary & Compliance Officer Kerala Ayurveda Ltd (BSE: 530163) appointed Mr. Binu Thomas as Company Secretary and Compliance Officer, effective 09 Jun'26. Mr. Thomas is a Fellow Member of ICSI with an MBA and possesses over 10 years of post-qualification experience in secretarial and compliance functions for listed entities. Prior to this role, he served as Company Secretary and Compliance Officer at Harrisons Malayalam Limited. This appointment is a key management personnel change under SEBI Listing Regulations.
Appointment of New Company Secretary
Change in Management · 09 Jun 2026, 4:11 pm
Kerala Ayurveda Appoints New Company Secretary and Compliance Officer Kerala Ayurveda Ltd. appointed Mr. Binu Thomas as Company Secretary and Compliance Officer, effective 09 Jun'26. Mr. Thomas is a Fellow Member of ICSI with an MBA and over 10 years of post-qualification experience in secretarial and compliance roles at listed entities. He previously served as Company Secretary and Compliance Officer at Harrisons Malayalam Limited. This appointment follows the approval of the Board of Directors in their meeting on 09 Jun'26.
Press Release
Press Release · 26 May 2026, 2:29 am
KAL Targets Rs. 200 Cr Revenue in FY27 Amidst Strategic Growth Investments Kerala Ayurveda Ltd (KAL) reported FY26 revenue of Rs. 145.4 Cr, a 22% YoY growth excluding discontinued business. The standalone entity surpassed Rs. 100 Cr for the first time. Consolidated EBITDA margin improved 20 bps to -2.4%, while PAT was Rs. -16.3 Cr vs. Rs. -14 Cr YoY due to higher interest costs. KAL targets Rs. 200 Cr revenue for FY27, a 50% operating growth, driven primarily by its Global E-Product business. The company aims for operating breakeven by Jan'27 despite heavy marketing investments.
Appointment of Internal Auditor and Cost Auditor
Change in Management · 26 May 2026, 1:35 am
Kerala Ayurveda Appoints New Internal and Cost Auditors for FY27 Kerala Ayurveda's Board, at its meeting on 25 May'26, approved key appointments for FY27. Mr. Alphonse Scaria (Firm Reg. No.: 0179118S) has been named the Internal Auditor. Additionally, M/s. SLR & Associates, Kochi (Firm Reg. No. 006310S) has been appointed as the Cost Auditor. The Board also approved the audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26, which received an unmodified opinion from the statutory auditors. These appointments are effective for the fiscal year 2026-27.
Financial Results for the Year Ended 31st March 2026
Financial Result · 26 May 2026, 1:31 am
Kerala Ayurveda Reports Q4 & FY26 Results, Appoints New Auditors Kerala Ayurveda's Board on 25 May'26 approved audited financials for the quarter and year ended 31 Mar'26. On a consolidated basis for FY26, revenue from operations was Rs. 13,114.57 lakhs, up 9.0% YoY from Rs. 12,033.35 lakhs. The net loss after tax widened to Rs. 1,632.46 lakhs from Rs. 1,395.90 lakhs in FY25. The Board also appointed Mr. Alphonse Scaria as Internal Auditor and M/s. SLR & Associates as Cost Auditors for FY 2026-27. Statutory auditors issued an unmodified opinion.
Outcome of Board meeting held on 25th May 2026
Outcome · 26 May 2026, 1:14 am
Kerala Ayurveda Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 3,474 (+10.9% YoY | +5.4% QoQ) ■ EBITDA: -710 (+30.0% YoY | -368.9% QoQ) ■ EBITDA Margin (%): -20.4 (+1195 bps YoY | -1584 bps QoQ) ■ PAT: -776 (+50.0% YoY | -74.6% QoQ) ■ EPS (INR): -5.83 (+54.4% YoY | -53.0% QoQ)